Completed NA NCT00479375

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Screening

Sponsor: Europe Against Cancer (European Union Directorate General XII- Public Health)

Conditions Cervical Cancer Cervical Intraepithelial Neoplasia

Interventions Adding Human Papillomavirus testing to organised cervical screening

Updated 5 times since 2017 Last updated: May 25, 2007 Started: May 31, 1997 Completion: May 31, 2007

Listed as NCT00479375, this NA trial focuses on Cervical Cancer and Cervical Intraepithelial Neoplasia and remains completed. Sponsored by Europe Against Cancer (European Union Directorate General XII- Public Health), it has been updated 5 times since 1997, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Europe Against Cancer (European Union Directorate General XII- Public Health)
Skane University Hospital
Swedish Cancer Society

Data source: Skane University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Malmo, Sweden